U.S. FDA lifts restrictions on Glaxo diabetes drug Avandia

November 25, 2013 8:05 PM

15 0

U.S. FDA lifts restrictions on Glaxo diabetes drug Avandia

(Reuters) - Health regulators on Monday said they would lift restrictions on the use of GlaxoSmithKline Plc's once widely used diabetes drug Avandia after determining that it did not increase the risk of heart attacks.

The U.S. Food and Drug Administration, following its review of a large clinical trial called Record, said it found that the trial showed no elevated risk of heart attack or death in patients being treated with Avandia when compared with standard-of-care diabetes drugs.

Read more

To category page

Loading...